Search
CELL BANK Website

Back Back
Cell No. : Cell Name
RCB5379 : P3-X63-Ag8-U/hZC3H12D・TFL-21-7G  update : 2024/11/11
Comment
Comment from the depositorMouse hybridoma cell line producing anti-human ZC3H12D(TFL) monoclonal antibody.
Terms and conditions1) The use of the BIOLOGICAL RESOURCE need sapre-approval letter by the developer, Dr.Toshimitsu Matsui (matsui.kobe@gnlail.com). 2) The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. 3) In publishing research results obtained by the use of the BIOLOGICAL RESOURCE, a citation of the literature ref. (J Immunol. 2014:192(4):1512-1524) designated by the DEPOSITOR is required.
Remarks
Order Form Order Form(C-0005.pdf)   Approval Form(C-0006.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
Basic information Depositor KATAYAMA, Yoshio
Originator MATSUI, Toshimitsu
Year of deposit 2021
Another name anti-hZC3H12D・TFL//P3X63Ag8U1
Cloning (depositor) Yes
_Date (depositor) 2009
Animal _mouse x mouse < Hybrid
Classification hybrid cells
Lifespan infinite
Morphology lymphocyte-like
Cellosaurus(Expasy) CVCL_A7BN
hybridoma Fusion_cell_1 name P3-X63-Ag8-U
Fusion_cell_1 strain mouse
Fusion_cell_2 name lymph node
Fusion_cell_2 strain mouse, C57BL
Fusion_cell_2 gender Unknown
Fusion method 50% PEG
Antibody name hZC3H12D・TFL-21-7G
Subclass IgG2b
Immunogen Human TFLp36-GST fusion recombinant protein
Antigen_name human TFL (ZC3H12D)p58 & p36
Antigen_m.w. 58/36k-Da
Antigen_character Zinc finger (ZF) CCCH domain containing protein 12D (ZC3H12D/TFL/Regnase-4
Antigen_epitope TFLp36 321 aa
Antigen_positive lymphocytes・spleen/lymph node
deposit info
lot info
Medium Medium List
Culture type Suspension cells Suspension cells
Culture method 浮遊細胞の培養に関する一般的な注意(Japanese)
Culture medium RPMI-1640+10%FCS PMI1640 + 10% FBS
Antibiotics penicillin, kanamycin Free
Passage method dilution
Culture information Passage ratio 1 : 2-3 split
SC frequency Subculture : 2 times/week
Temperature 37 ℃ 37 ℃
CO2 concentration 5 % 5 %
Freeze medium medium + 10% DMSO Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma/Acholeplasma (-)
Antibody subclass IgG2b(Kappa)
Reference information Reference 2
User's Publication 0


To topTop
Reference
15426  Tomita T, Kato M, Mishima T, Matsunaga Y, Sanjo H, Ito KI, Minagawa K, Matsui T, Oikawa H, Takahashi S, Takao T, Iwai N, Mino T, Takeuchi O, Maru Y, Hiratsuka S.  Extracellular mRNA transported to the nucleus exerts translation-independent function  Nat Commun  2021  12(1):3655  PubMed ID: 34135341   DOI: 10.1038/s41467-021-23969-1
3252  Kentaro Minagawa, Kanako Wakahashi, Hiroki Kawano, Shinichiro Nishikawa, Chie Fukui, Yuko Kawano, Noboru Asada, Mari Sato, Akiko Sada, Yoshio Katayama, Toshimitsu Matsui  Posttranscriptional modulation of cytokine production in T cells for the regulation of excessive inflammation by TFL  J Immunol  2014  192(4):1512-24  PubMed ID: 24415781   DOI: 10.4049/jimmunol.1301619

To topTop
User's Publication



Back Back Return Top Page